New hope for sickle cell pain? ketamine study launches for kids
NCT ID NCT07369024
Summary
This study is testing if adding a low dose of the drug ketamine to standard opioid pain medicine works better for children and young adults with sickle cell disease during a severe pain crisis. Researchers will compare pain levels, opioid use, and hospital stays between two groups: one getting the standard treatment plus ketamine, and one getting the standard treatment alone. The goal is to find a safer, more effective way to manage these painful episodes.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAIN MANAGEMENT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Harbor UCLA Medical Center
RECRUITINGTorrance, California, 90509, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.